MINNEAPOLIS--(BUSINESS WIRE)--#EPeeps--Imricor Medical Systems, Inc. (ASX:IMR) Imricor, the global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation products, is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with GE HealthCare.
Under the terms of the MOU, GE HealthCare and Imricor intend to collaborate to interface Imricor�s Advantage-MR EP Recorder/Stimulator and Northstar-MR 3D Mapping System with GE HealthCare MRI scanners. A successful collaboration will enable cardiac electrophysiology (EP) ablation procedures guided by real-time MRI, using Imricor�s catheters and other disposable devices, to be performed on the GE HealthCare MRI platform. The collaboration with GE HealthCare would expand Imricor�s potential to interface with GE HealthCare�s new and currently installed MRI scanners.
Imricor�s short-term goal is to allow sites with GE HealthCare MRI systems to participate in the upcoming �Vision-MR Ablation of Atrial FLutter� or VISABL-AFL clinical trial in the US and �Vision-MR Ablation of Ventricular Tachycardia� or VISABL-VT clinical trial in Europe. The Company�s overall goal is to broaden in the choices physicians and hospitals have when choosing an MRI platform for their iCMR labs.
�Imricor�s innovative technology has the potential to bring significant benefit to a large number of cardiac arrhythmia patients,� said Anja Brau, PhD, General Manager, GE HealthCare MR Clinical Solutions and Research Collaborations. �GE HealthCare has a long-standing history of applying MR to therapy guidance and control; we would be pleased to add Imricor�s capabilities to provide our customers with more options to treat their patients.�
�We are thrilled at the prospect of expanding the portfolio of MRI scanners that support Advantage-MR and Northstar-MR technology,� said Steve Wedan, Imricor�s CEO and Chair. �The addition of GE HealthCare will give physicians and hospitals significantly more flexibility to use the MRI hardware of their choice, when providing real-time iCMR ablations for their patients. We are grateful to our existing customers who have embraced our real-time iCMR ablation technology, and look forward to making the benefits of this technology even more widely available.�
About Imricor
Please visit http://imricor.com/investors/about-imricor/ for more information about Imricor, Foreign Ownership Restrictions, and Forward-Looking Statements.
Contacts
Nick Twohy
Vice President of Marketing, Imricor
Email: [email protected]
Phone: +1 952 818 8407
